drugset / Trial / NCT01908400

Safety and Efficacy of BMMNCin Patients With Mental Retardation

NCT01908400 ↗

Phase 1/2 Unknown 15 enrolled Chaitanya Hospital, Pune
NaSingle-groupOpen-labelTreatment

Summary

Mental retardation is a condition diagnosed before age 18 that includes below-average general intellectual function, and a lack of the skills necessary for daily living. Mental retardation affects about 1 - 3% of the population. There are many causes of mental retardation, but find a specific reason in only 25% of cases.Bone marrow derived stem cells are used in this condition to prove its safety and efficacy .

Timeline

Start
2014-09
Primary completion
2016-11
Completion
2016-11

Drugs

EvaluationDrugModalityDoseRoute
Subject BMMNCs Cell therapy — Intravenous

Indications

No indication recorded.